HKPD 9zt.hk: מכפיל EV/EBITDA
Hong Kong Pharma Digital (HKPD) provides digital services for Hong Kong pharmacies, yet its micro-cap status and pressure from tech giants render the company's cash flows extremely volatile. The EV/EBITDA trend, which currently stands at 0.00, clearly illustrates the market valuation of the asset. Meanwhile, the business relies on a loyal patient base, which guarantees steady demand for medications due to users' habits of placing regular orders via the platform.
פילוחים אנליטיים ודוחות נתונים של חברת 9zt.hk (HKPD)
The metric is calculated as the ratio of total enterprise value (market capitalization plus net debt) to earnings before interest, taxes, depreciation, and amortization. This metric determines the objective value of assets with high leverage, where rising values signal market optimism, while overvaluation indicates a risk of correction. For the Hong Kong Pharma Digital (HKPD) digital ecosystem, the current EV/EBITDA valuation reflects the investment attractiveness of integrating telemedicine and online pharmacy.
